Qube Research & Technologies (QRT)
INMB icon

Qube Research & Technologies (QRT)’s INmune Bio INMB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,298
Closed -$62.1K – 3674
2024
Q4 		$62.1K Buy
+13,298
New +$69.3K ﹤0.01% 3070
2024
Q3 		– Sell
-3,384
Closed -$29.8K – 3698
2024
Q2 		$29.8K Sell
3,384
-40,781
-92% -$402K ﹤0.01% 2831
2024
Q1 		$519K Buy
44,165
+14,728
+50% +$178K ﹤0.01% 2517
2023
Q4 		$331K Buy
+29,437
New +$247K ﹤0.01% 2530
2020
Q4 		– Sell
-23,981
Closed -$247K – 1993
2020
Q3 		$247K Buy
+23,981
New +$244K ﹤0.01% 1321

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Praetorian PR Rincon, Puerto Rico $275M AUM 84.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s INMB Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of INmune Bio (INMB) in Q1 2025, closing a stake of 13,298 shares — an estimated $62.1K sold.

Qube Research & Technologies (QRT) first reported a position in INMB in Q3 2020 and held it in 5 quarters. The position peaked at $519K in Q1 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining INmune Bio position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 13,298 INmune Bio shares in Q1 2025, an estimated $62.1K.
  • Qube Research & Technologies (QRT) first reported a position in INmune Bio in Q3 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s INmune Bio position peaked at $519K in Q1 2024.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.